Collegium Pharmaceutical (COLL) News Today → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free COLL Stock Alerts $37.86 -0.20 (-0.53%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCOLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024msn.com - May 10 at 12:34 AMCollegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimatesmsn.com - May 9 at 7:33 PMCollegium Announces CEO Transitionfinance.yahoo.com - May 9 at 7:33 PMCollegium Pharmaceutical CEO Joe Ciaffoni Steps Downmarketwatch.com - May 9 at 7:33 PMCollegium Reports First Quarter 2024 Financial Resultsglobenewswire.com - May 9 at 4:02 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Holdings Raised by LSV Asset Managementmarketbeat.com - May 9 at 6:40 AMWarner Bros. Discover earnings, Fedspeak: What to watchfinance.yahoo.com - May 8 at 11:13 PMCollegium Pharmaceutical earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 8 at 6:12 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Analystsamericanbankingnews.com - May 8 at 4:52 AMAnalysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Rocket Pharmaceuticals (RCKT)markets.businessinsider.com - May 7 at 10:54 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by New York State Common Retirement Fundmarketbeat.com - May 4 at 5:19 AMAnalysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Jazz Pharmaceuticals (JAZZ) and KalVista Pharmaceuticals (KALV)markets.businessinsider.com - May 3 at 11:58 AMCollegium Pharmaceutical (NASDAQ:COLL) Downgraded by StockNews.com to Buyamericanbankingnews.com - May 2 at 5:40 AMCollegium Pharmaceutical (COLL) Scheduled to Post Quarterly Earnings on Thursdayamericanbankingnews.com - May 2 at 4:08 AM3 Popular Pharma Stocks Worth Buying Nowstocknews.com - May 1 at 1:04 PMAvalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officerfinance.yahoo.com - May 1 at 10:13 AMCollegium Pharmaceutical (NASDAQ:COLL) Trading Up 3.8%marketbeat.com - April 30 at 1:37 PMCollegium enters authorized generic agreement with Hikma for Nucynta franchisemsn.com - April 29 at 10:52 AMCollegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ERfinance.yahoo.com - April 29 at 10:52 AMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Acquired by Federated Hermes Inc.marketbeat.com - April 26 at 5:31 AMCollegium to Report First Quarter 2024 Financial Results on May 9, 2024globenewswire.com - April 25 at 8:00 AMCollegium Pharmaceutical (NASDAQ:COLL) Upgraded to "Strong-Buy" by StockNews.commarketbeat.com - April 23 at 11:12 PMCollegium Pharmaceutical Incmoney.usnews.com - April 23 at 10:29 AMOptimistic Buy Rating for Collegium Pharmaceutical: Growth and Market Position Analysismarkets.businessinsider.com - April 12 at 7:57 PMCritical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Knowmarkets.businessinsider.com - April 11 at 2:00 PMCollegium Pharmaceutical (NASDAQ:COLL) Trading Down 3.9%marketbeat.com - April 11 at 1:48 PMCollegium Pharmaceutical's (COLL) Buy Rating Reiterated at Needham & Company LLCmarketbeat.com - April 11 at 8:26 AMCollegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026globenewswire.com - April 11 at 8:00 AMCollegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Knowfinance.yahoo.com - April 9 at 11:27 PMPeregrine Capital Management LLC Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - April 9 at 3:30 PMNovan is gone. But its lead drug lives on with new companybizjournals.com - April 4 at 9:12 PMLigand Pharmaceuticals Announces Launch Of Pelthos; Scott Plesha To Assume Leadership Of Pelthosmarkets.businessinsider.com - April 3 at 2:04 PMCollegium to Participate in 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 3 at 9:04 AMAssenagon Asset Management S.A. Sells 79,790 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 30 at 4:50 AMCollegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year High at $40.95marketbeat.com - March 28 at 10:52 AMPacer Advisors Inc. Purchases 883,380 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 25 at 8:24 AMCollegium Pharmaceutical Inc.wsj.com - March 23 at 6:25 AMCollegium Pharmaceutical (NASDAQ:COLL) Reaches New 1-Year High at $39.96marketbeat.com - March 22 at 1:44 PMCollegium Pharmaceutical (NASDAQ:COLL) Upgraded by StockNews.com to Strong-Buymarketbeat.com - March 21 at 11:15 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - March 19 at 6:33 AMCollegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year High at $38.48marketbeat.com - March 15 at 12:38 PMBuy Rating Affirmed for KalVista Pharmaceuticals on Strong Phase 3 Results and Solid Financial Positionmarkets.businessinsider.com - March 11 at 9:53 PMQube Research & Technologies Ltd Acquires 111,394 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 10 at 5:21 AMTamarack Advisers LP Sells 190,000 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 8 at 5:27 PMCollegium Pharmaceutical (NASDAQ:COLL) Reaches New 52-Week High at $38.39marketbeat.com - March 8 at 1:24 PMRubric Capital Management LP Has $70.96 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)marketbeat.com - March 6 at 6:45 AMCOLL Mar 2024 50.000 callfinance.yahoo.com - March 5 at 11:02 AM5 Best Small Cap Pharma Stocks to Invest Ininsidermonkey.com - March 4 at 11:21 PMCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Acquired by Trexquant Investment LPmarketbeat.com - March 1 at 6:48 AMInsider Sell: EVP & Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ...finance.yahoo.com - February 29 at 2:27 AM Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. COLL Media Mentions By Week COLL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COLL News Sentiment▼0.450.43▲Average Medical News Sentiment COLL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COLL Articles This Week▼153▲COLL Articles Average Week Get Collegium Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MIRM News Today MNKD News Today PCRX News Today SYRE News Today VRNA News Today ABCL News Today BLTE News Today PRTA News Today GYRE News Today IRWD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COLL) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
